Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Head-Neck
Study Phase
Phase 3
Study Completion Date
January 2011
NCT00265941Uploaded 12-17-2019
Access via NCI by Request
PDS UID: nci-data-381
A Randomized Phase III Trial of Concurrent Accelerated Radiation and Cisplatin Versus Concurrent Accelerated Radiation, Cisplatin, and Cetuximab (C225) [Followed by Surgery for Selected Patients] for Stage III and IV Head and Neck Carcinomas
Files: NCT00265941-D2
Data DictionaryNCT00265941-D2-Data-Dictionary.pdf
DATANCT00265941-D2-Dataset.csv
OTHERREADME.pdf
Files: NCT00265941-D1
Data DictionaryNCT00265941-D1-Data-Dictionary_1.pdf
DATANCT00265941-D1-Dataset.csv
OTHERREADME.pdf